Potential Lung Cancer Vaccine Shows Promise
(SACRAMENTO, Calif.) - Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer.
The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.
Though tecemotide, also known as Stimuvax, has shown great potential at times, the recent Phase III trial found no overall survival benefit for patients with non-small cell lung cancer (NSCLC). However, further analysis showed one group of patients, who received concurrent chemotherapy and radiation followed by tecemotide, did benefit from the vaccine. As a result, tecemotide's manufacturer, Merck KGaA, is sponsoring additional post-clinical animal and human studies, so far with good results.
"There aren't any good options for patients with inoperable stage III lung cancer following mainline chemotherapies," said UC Davis Professor of Medicine and lead author Michael DeGregorio. "We are looking at tecemotide as a potential maintenance therapy to prolong survival and improve quality of life."
Tecemotide activates an immune response by targeting the protein MUC1, which is often overexpressed in lung, breast, prostate and other cancers. The vaccine stimulates production of interferon gamma and MUC1-targeted killer T-lymphocytes, which seek out and destroy MUC1 cancer cells.
The team, which included investigators from the UC Davis School of Veterinary Medicine and the Department of Radiation Oncology, wanted to know if cisplatin/tecemotide treatments, along with radiation therapy, could boost the immune response and alter lung cancer's trajectory, stabilizing the disease.
The study produced a number of positive results. Tecemotide increased interferon gamma levels and boosted the T-cell response to MUC1-expressing cancer cells. When administered by themselves, both tecemotide and cisplatin reduced the number of lung tumors. However, combining these therapies enhanced their impact, suggesting that tecemotide may increase cisplatin's anticancer activity.
Though radiation therapy did reduce the number of lymphocytes, it did not appear to hamper the immune response. In addition, interferon levels actually increased several hours after radiation treatments.
"Radiation may actually be helpful by exposing targets for the vaccine," said DeGregorio.
While this study revives hope for tecemotide as a potential NSCLC therapy, there are still questions to be answered. Researchers need to further refine these therapies to determine which protocols provide the best survival benefits. In addition, tecemotide can only be effective if it does not exhaust the immune system in the process. Still, the research provides a ray of hope for patients with few options.
"We believe this vaccine could be coupled with standard treatments to create a maintenance therapy," said DeGregorio. "If we can help patients with a life expectancy of 18 to 20 months increase that to 30 months or more, with a high quality of life, that's a big benefit."
Other authors included: Chiao-Jung Kao, Gregory T. Wurz, Arta M. Monjazeb, Daniel P. Vang, Timothy B. Cadman, Stephen M. Griffey, all of UC Davis; and Michael Wolf of Merck.
This study was funded by a grant from Merck KGaA.
Print This Article
Placer County News HeadlinesRoseville Developer Begins Senior Community in Elk GroveUSA Properties Fund will hold a groundbreaking ceremony for Arbor Creek Senior Apartments at 10:30 a.m., Aug. 4, at the project site located at Elk Grove-Florin and Calvine roads
Rep. Tom McClintock Announces August Town Hall MeetingsRoseville, CA -- U.S. Rep. Tom McClintock (CA-04) has announced a series of town hall meetings in August.
Lincoln Man Serving Aboard the Navy's USS SomersetPetty Officer 1st Class Brian West, an aviation boatswain's mate from Lincoln, Calif. and 2003 graduate of Lincoln High School, is serving in the U.S. Navy aboard USS Somerset
California Would Create More Jobs Without Prop 30In his recent piece for The Sacramento Bee, "State's job growth defies predictions after tax increases," David Cay Johnston argues that California's recent job creation numbers prove
Sacramento County Opposes Bay Delta Conservation PlanThis week the Sacramento County Board of Supervisors formally submitted comments challenging the findings of the Bay Delta Conservation Plan (BDCP) state environmental
Roseville to Host Senior Softball Western National ChampionshipsRoseville will play host this August to the Senior Softball Western National Championships
Roseville Crime Report Digest Update (7.29.14)Roseville, CA - The Roseville Police Department weekly crime report digest update for July 29, 2014.
Different Standards From Mortgage LendersJulie Jalone of MagnumOne Realty in Roseville, reports on a recent Fannie Mae survey which indicates there may be a growing difference in credit standards between small and large lenders. Which do you think has the tighter credit standards? Check out Julie's article and find out.
PCWA Comments on Bay Delta Conservation PlanDrought Watch: PCWA expresses concern about future water supply reliability for Placer County and claims EIR fails to consider key issues.
Honor Bowl Games at Del Oro August 2014ROCKLIN, CA. - William Jessup University announced today that it will serve as a sponsor for the Northern and Southern California 2014 Honor Bowl football games.
Tahoe Bike Classic Sept. 27 & 28The inaugural Tahoe Bike Classic will take over the Lake Tahoe basin this fall, September 27 & 28, 2014.
Lake Tahoe Marathon Returns September 14thArguably the most beautiful marathon in the world, the Lake Tahoe Marathon returns to Lake Tahoe on Sunday September 14, 2014. Since its inception in 1995, the Lake Tahoe Marathon has evolved into a premier running event